Results 181 to 190 of about 2,325,608 (312)
Severe Ulcerative Gastritis Associated With Pembrolizumab in a Patient With Metastatic Lung Adenocarcinoma: A Case Report and Review of Gastric Immune-Related Adverse Events. [PDF]
Costa MA +3 more
europepmc +1 more source
Variable Temperature Studies of Two Calcium Uranates α‐Ca3UO6 and Ca2UO5
The structures and thermal responses of the calcium uranates α‐Ca3UO6 and Ca2UO5 were investigated using in situ synchrotron x‐ray diffraction and neutron powder diffraction. Despite the very similar chemical compositions, the structural response of the two calcium uranates is shown to be complex and varied.
Maria K. Nicholas +8 more
wiley +1 more source
Moving past the usual suspects: a new framework for aural fullness. [PDF]
Bittar RSM, Mangia LRL, Mezzalira R.
europepmc +1 more source
Arabidopsis AUGMIN8 Contains Two Independent Microtubule Association Domains
ABSTRACT Plant cells create a plasma membrane‐associated network of microtubules that are nucleated by γ‐tubulin ring complexes primarily through microtubule‐dependent microtubule nucleation (MDMN). This dynamic array organizes into specific patterns in response to developmental and environmental cues to influence primary cell wall construction.
Naveen K. Chana +2 more
wiley +1 more source
PPAR-gamma regulates PFAS-mediated proinflammatory cytokines in lung epithelial cells. [PDF]
Shaikh SB +4 more
europepmc +1 more source
The European Medicines Regulatory Network plays a critical role in safeguarding public health through the assessment and supervision of human medicines. However, rapid scientific and technological advancements have exposed capability deficits across the network, threatening timely and effective regulatory decision‐making.
Naomi Beard +4 more
wiley +1 more source
Correction: The costs of subsidies and externalities of economic activities driving nature decline. [PDF]
Reyes-García V +9 more
europepmc +1 more source
We evaluated whether concomitant 5‐aminosalicylic acid (5‐ASA) influences clinical remission in patients with ulcerative colitis (UC) receiving Janus kinase inhibitors (JAKi). In this retrospective, multicenter cohort study, UC patients receiving tofacitinib (n = 181), upadacitinib (n = 313), or filgotinib (n = 139) were included.
Antonio Tursi +100 more
wiley +1 more source

